FDA Slaps New Safety Warning on GLP-1 Drugs

Who is covering this

1. Medscape Center Factuality: Mostly factual US 1 hour ago
   FDA Requires GLP-1 Labels to Add Rare Eye Condition Risk

   The FDA now requires information be added to the labels of GLP-1 receptor agonists about the potential increased risk for nonarteritic anterior ischemic optic neuropathy.

2. Medpagetoday Center Factuality: Mostly factual US 4 hours ago
   FDA Slaps New Safety Warning on GLP-1 Drugs

   (MedPage Today) -- The FDA is requiring manufacturers of all GLP-1 drugs to update their prescribing information to include a warning about the potential risk of non-arteritic anterior ischemic optic neuropathy (NAION), a rare but potentially blinding...